CYP1A2 showed a decrease of 53% during SARS-CoV-2 infection measured in blood samples from 18 COVID-19 patients, with an inverse correlation with interleukin 6 and C-reactive protein levels (Lenoir et al., 2021). This evidence concerns the gene CYP1A2 and COVID-19.